Osteopore Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.739x

Osteopore Ltd cash flow conversion efficiency. Based on the latest financial reports, Osteopore Ltd (OSX) has a cash flow conversion efficiency ratio of 0.739x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.28 Million ≈ $-903.25K USD) by net assets (AU$-1.73 Million ≈ $-1.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Osteopore Ltd (2016–2025)

Cash flow conversion efficiency of Osteopore Ltd from 2016 to 2025. This chart illustrates how Osteopore Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Osteopore Ltd stock price today for real-time trading data and today's change.

Osteopore Ltd Cash Flow Conversion Ratio Explained

Osteopore Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Osteopore Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Osteopore Ltd ranked by their cash flow conversion efficiency. Also see OSX market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Future Supply Chain Solutions Limited NSE:FSC	0.108x
Bonyf NV PA:MLBON	0.545x
Margaret Lake Diamonds Inc V:DIA	0.054x
GENERAL COPPER GOLD CORP. F:7S50	0.169x
Elevai Labs, Inc. Common Stock NASDAQ:ELAB	-0.119x
CYCLIQ Group Ltd AU:CYQ	-4.086x
Mobius Investment Trust PLC LSE:MMIT	-0.006x
VULTUS AB F:V06	0.733x

Annual Cash Flow Conversion Efficiency for Osteopore Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Osteopore Ltd from 2016 to 2025. Review free cash flow generation of Osteopore Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-1.73 Million ≈ $-1.22 Million	AU$-2.56 Million ≈ $-1.81 Million	1.481x	+114.69%
2024-12-31	AU$306.22K ≈ $216.67K	AU$-3.09 Million ≈ $-2.18 Million	-10.084x	-16.73%
2023-12-31	AU$432.60K ≈ $306.09K	AU$-3.74 Million ≈ $-2.64 Million	-8.639x	-355.31%
2022-12-31	AU$2.11 Million ≈ $1.49 Million	AU$-4.00 Million ≈ $-2.83 Million	-1.897x	-167.87%
2021-12-31	AU$5.37 Million ≈ $3.80 Million	AU$-3.81 Million ≈ $-2.69 Million	-0.708x	-262.52%
2020-12-31	AU$9.00 Million ≈ $6.37 Million	AU$-1.76 Million ≈ $-1.24 Million	-0.195x	+66.85%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-1.75 Million ≈ $-1.24 Million	-0.589x	-646.63%
2018-12-31	AU$4.23 Million ≈ $3.00 Million	AU$-334.12K ≈ $-236.41K	-0.079x	-1197.74%
2017-12-31	AU$-1.84 Million ≈ $-1.30 Million	AU$11.16K ≈ $7.90K	-0.006x	-104.48%
2016-12-31	AU$-1.36 Million ≈ $-959.71K	AU$-184.27K ≈ $-130.38K	0.136x	--

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies

Market Cap

$1.30 Million

AU$1.84 Million AUD

Market Cap Rank

#30458 Global

#1783 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.03

All Time High

AU$15.65